Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02912507 · ClinicalTrials.gov registry record · NA
Split-tattoo Study Comparing the Safety and Efficacy of 670nm Picosecond Laser Versus 755 nm for Tattoo Removal
A NA study, sponsored by Cutera.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT02912507 is a NA study that has completed, run by Cutera. The registered enrollment target is 11 participants.
The verdict
NCT02912507, a NA study, has completed, sponsored by Cutera.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
Study to evaluate safety and efficacy of treatment with the investigational Cutera enlighten laser for tattoo removal as compared to treatment with the Cynosure PicoSure laser
Interventions
- DEVICE Cutera enlighten laser
- DEVICE CynoSure PicoSure 755nm laser
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2016-09-09 |
| Est. Completion | 2017-08-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02912507
The ClinicalTrials.gov registry entry for NCT02912507 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cutera, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cutera enlighten laser is the first listed.
NCT02912507 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02912507 about?
NCT02912507 is a clinical study titled "Split-tattoo Study Comparing the Safety and Efficacy of 670nm Picosecond Laser Versus 755 nm for Tattoo Removal". Study to evaluate safety and efficacy of treatment with the investigational Cutera enlighten laser for tattoo removal as compared to treatment with the Cynosure PicoSure laser
What is the current status of trial NCT02912507?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2016-09-09. Estimated completion is 2017-08-16.
What interventions are being tested in trial NCT02912507?
The interventions under investigation include: Cutera enlighten laser (DEVICE), CynoSure PicoSure 755nm laser (DEVICE).
Who is sponsoring clinical trial NCT02912507?
This trial is sponsored by Cutera, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.